# Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients

> **NCT03755895** · PHASE2 · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 68 (actual)

## Conditions studied

- Cancer
- Brachytherapy

## Interventions

- **OTHER:** formal hypnosis
- **DRUG:** Kalinox

## Key facts

- **NCT ID:** NCT03755895
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-02
- **Primary completion:** 2022-05-17
- **Final completion:** 2022-05-25
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755895, "Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03755895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*